If you are researching non stimulant ADHD medication, you may be looking for an alternative to stimulants or trying to understand a clinician’s recommendation. Several medications can help with adult ADHD, but they differ in approval status, how they work, side effects, and monitoring needs. This guide explains those differences without recommending a particular prescription. For the broader treatment picture, start with our guide to ADHD medication for adults and key treatment questions.

Key takeaways

  • Atomoxetine and extended-release viloxazine are FDA-approved non-stimulant options for adult ADHD.
  • Some other medications are prescribed off-label for adults, depending on individual needs.
  • Non-stimulant does not mean risk-free, immediately effective, or suitable for everyone.
  • Follow-up should review everyday functioning, side effects, physical health, and mental health.

What is non-stimulant ADHD medication?

Non-stimulants are medications used to treat ADHD that are not classified as stimulants. They affect brain signaling involved in attention and behavioral regulation, although their mechanisms differ. They are not interchangeable, and a medication that helps one person may be ineffective or difficult to tolerate for another.

For adults, atomoxetine and extended-release viloxazine have FDA approval for ADHD. Other medicines, including bupropion and certain alpha-2 adrenergic agonists, may be considered off-label. Off-label means the FDA has not approved that particular use, age group, or formulation; it does not automatically mean the treatment is inappropriate.

The National Institute of Mental Health’s ADHD overview describes medication and behavioral approaches as treatment options. Medication decisions should follow a careful evaluation, including whether attention problems reflect ADHD, another condition, or several overlapping concerns.

Why might a clinician recommend a non-stimulant?

Stimulants help many adults, but they are not the right choice for every situation. A clinician may discuss a non-stimulant because of side effects, an incomplete response, medical considerations, personal preference, or concerns about misuse. The decision should reflect your history rather than a blanket assumption that one category is safer.

  • Tolerability: A previous medication may have caused unacceptable sleep, appetite, mood, or physical effects.
  • Medical history: Heart conditions, blood pressure, and other health issues can affect medication selection.
  • Other mental health needs: Anxiety, depression, bipolar symptoms, or substance use may change the treatment plan.
  • Practical preferences: Your daily routine and willingness to take medication consistently matter.
  • Past response: A clinician may reconsider the diagnosis, dose, formulation, or medication category when treatment has not helped.

Having anxiety does not automatically rule out stimulants or guarantee that a non-stimulant will work better. Likewise, a history of substance use deserves individualized discussion, not an automatic exclusion from ADHD treatment. Non-stimulants can still have significant interactions and require monitoring.

If you are comparing stimulant options as well, our article on Vyvanse vs. Adderall for adult ADHD explains another part of that conversation. A comparison article cannot determine which medication is appropriate for you.

Ready to start treatment?

MVBH's outpatient mental health program in Amesbury, MA, plus Full Day and Half Day Treatment, gives adults structured, evidence-based care without a hospital stay. Call 978-233-9597 today or verify your insurance in minutes.

How do the main non-stimulant options compare?

The table below separates medications approved for adult ADHD from options that may be used off-label. It is a discussion aid, not a ranking. Formulation matters: approval for one extended-release product does not make every version of the same medication approved for ADHD.

Medication categoryAdult ADHD status in the USWhy it may be discussedImportant follow-up concerns
AtomoxetineFDA-approved for adultsA non-stimulant option that affects norepinephrine signalingBlood pressure, pulse, appetite, sleep, mood, urinary or sexual effects, and rare liver problems
Extended-release viloxazineFDA-approved for adultsAnother non-stimulant option affecting norepinephrine signalingBlood pressure, pulse, sleepiness or insomnia, mood changes, and medication interactions
Extended-release guanfacine or clonidineAdult ADHD use is off-label; certain products are approved for children and adolescentsSometimes considered when individual symptoms or treatment history support their useSleepiness, low blood pressure, slow pulse, dizziness, and risks from abrupt discontinuation
BupropionOff-label for ADHDSometimes considered when depression or other individual factors also shape treatmentInsomnia, blood pressure, mood changes, seizure risk, and contraindications

Atomoxetine

Atomoxetine is a selective norepinephrine reuptake inhibitor. It is usually taken consistently rather than only on demanding days. Potential side effects include nausea, reduced appetite, dry mouth, constipation, and sleep changes. Some adults also experience urinary or sexual side effects.

MedlinePlus information on atomoxetine explains its warnings, interactions, and precautions. Its boxed warning concerns increased suicidal thinking in children and adolescents. Adults should still promptly report new or worsening mood symptoms. Rare liver injury is another reason to discuss warning signs, such as yellowing skin or eyes and dark urine.

Extended-release viloxazine

Extended-release viloxazine is also approved for adult ADHD. Possible side effects include insomnia, sleepiness, fatigue, nausea, and appetite changes. Its boxed warning addresses suicidal thoughts and behaviors, so changes in mood or behavior require attention. It can also increase blood pressure and heart rate.

Viloxazine has important medication interactions. Bring a complete medication and supplement list to the prescriber rather than assuming it can be added safely to an existing regimen. A history of bipolar disorder or possible manic symptoms also needs discussion before starting treatment.

Other off-label options

Guanfacine and clonidine affect alpha-2 adrenergic receptors. In adults, their use for ADHD is off-label, and the evidence base differs from that for approved adult treatments. They can cause sedation and lower blood pressure or pulse. MedlinePlus guidance on guanfacine cautions against stopping it suddenly because blood pressure can rise.

Bupropion is an antidepressant sometimes considered off-label for adult ADHD, particularly when depression is also part of the clinical picture. It is not suitable for everyone. MedlinePlus information on bupropion explains seizure-related precautions, including concerns for people with seizure disorders or certain eating disorders. It can also cause insomnia and may trigger mania in susceptible people.

How long does non-stimulant ADHD medication take to work?

Many non-stimulants work gradually. Some changes may appear earlier, but a fair assessment often requires several weeks, including time at a clinician-selected dose. The timeline depends on the medication, dose adjustments, side effects, and whether it is taken as prescribed. There is no single waiting period that fits every option.

Ask your prescriber what early improvement might look like and when the medication should be reassessed. Useful signs may include finishing tasks more reliably, interrupting less often, or managing transitions with less difficulty. Feeling more alert is not the only measure, and an absence of noticeable sensation does not necessarily mean nothing is changing.

Do not increase the dose, add another medication, or stop treatment to test its effects without guidance. If side effects interfere with daily life, contact the prescriber rather than waiting silently for the next appointment.

What risks and health history should you discuss?

Before prescribing, a clinician should review both mental and physical health. Mention previous medication reactions, fainting, heart disease, blood pressure problems, liver conditions, seizures, eating disorders, and pregnancy or breastfeeding plans when relevant. Share any family history your clinician asks about, including serious heart conditions or bipolar disorder.

Be specific about sleep, alcohol, cannabis, other substances, caffeine, and over-the-counter products. Medicines for depression, blood pressure, allergies, or other conditions can affect the plan. A pharmacist can also help identify interactions, but medication changes should be coordinated with the prescriber.

Discuss periods of unusually elevated or irritable mood, reduced need for sleep, or impulsive behavior that is different from your usual ADHD pattern. These symptoms may require further assessment. ADHD medication does not replace treatment for every co-occurring condition, and attention difficulties alone do not establish an ADHD diagnosis.

Ask which symptoms require a routine call versus urgent help. Seek urgent medical evaluation for serious symptoms such as chest pain, fainting, or a severe allergic reaction. For suicidal thoughts or a mental health crisis, call or text 988. Call 911 for an immediate emergency.

What should follow-up and everyday support include?

A useful follow-up plan connects medication effects to the problems that brought you into care. Choose a few observable goals before starting. This makes it easier to distinguish meaningful improvement from day-to-day fluctuations and helps prevent dose changes based only on a particularly difficult day.

  1. Set practical goals: Examples include fewer missed appointments, starting paperwork sooner, or completing a morning routine.
  2. Track patterns: Briefly note sleep, appetite, side effects, and functioning without turning tracking into another overwhelming task.
  3. Review physical measures: Ask whether blood pressure, pulse, weight, or other monitoring is needed.
  4. Plan check-ins: Clarify when to follow up and whom to contact between visits.
  5. Reassess the whole plan: If progress is limited, discuss adherence, sleep, diagnosis, co-occurring conditions, and behavioral support.

Medication can be paired with therapy and practical strategies for organization, task initiation, and managing emotions. Calendars, reminders, manageable task steps, and consistent sleep routines may support treatment. These tools are not a substitute for indicated medical care, and difficulty using them is not a personal failure.

How can adults discuss ADHD treatment at MVBH?

Merrimack Valley Behavioral Health is an adult outpatient mental health treatment center at 77 Elm St, Amesbury, MA 01913. Adults researching ADHD treatment can discuss their concerns and ask how their needs fit available services. Choosing a setting involves more than choosing a prescription.

Some people need Outpatient care, while others may need more structured support for broader mental health concerns. MVBH also offers Dual Diagnosis care for co-occurring mental health and substance use needs. The appropriate level depends on an individualized assessment.

To ask about next steps, contact Admissions or call 978-233-9597. Bring your medication history, current medication list, and a few examples of how symptoms affect daily life. Ask who would manage prescriptions and follow-up. MVBH does not provide onsite detox and is not an emergency service.

Frequently asked questions

Which non-stimulant medications are approved for adult ADHD?

Atomoxetine and extended-release viloxazine are FDA-approved for ADHD in adults. Other medications, such as bupropion or certain guanfacine and clonidine formulations, may be prescribed off-label for adults. Approval depends on the medication, formulation, and age group. Ask your prescriber whether a proposed treatment is approved for adult ADHD, what evidence supports it, and how its benefits and risks fit your health history.

Are non-stimulant ADHD medications safer than stimulants?

Not automatically. Non-stimulants have different risks rather than no risks. Some can raise blood pressure or heart rate; others can lower them or cause significant sleepiness. Certain options have important mood warnings, interactions, or contraindications. Safety depends on your medical history, other medications, and monitoring. A clinician can explain why a particular option may be preferable for you without assuming that an entire medication category is always safer.

Can non-stimulant ADHD medication help if I also have anxiety?

A non-stimulant may be considered when ADHD and anxiety occur together, but anxiety does not automatically make it the best choice. Treatment depends on which symptoms are most disruptive, previous medication responses, sleep, and other health factors. Some medications can cause insomnia or other effects that complicate anxiety. Your clinician should assess both conditions and discuss whether therapy, medication, or a combined approach is appropriate.

How will I know whether a non-stimulant is working?

Look for changes in everyday functioning, not just a noticeable feeling after taking a dose. You might find it easier to start tasks, follow conversations, keep appointments, or manage impulsive reactions. Many non-stimulants need several weeks and dose adjustments before they can be fairly assessed. Agree on specific goals and a review timeline with your prescriber, and track side effects alongside any benefits.

Can I stop a non-stimulant if I do not like the side effects?

Contact your prescriber before changing or stopping treatment. The safest approach depends on the medication and the symptoms you are experiencing. Guanfacine and clonidine, for example, can cause rebound increases in blood pressure if stopped abruptly. Severe symptoms may require urgent medical evaluation rather than a routine appointment. Ask in advance which side effects warrant a call, which require emergency care, and how any discontinuation would be managed.

Don't wait for things to get worse. Call Merrimack Valley Behavioral Health at 978-233-9597 to start adult care in our outpatient mental health program or compare Half Day Treatment (IOP) and Full Day Treatment (PHP). Same-week assessments may be available.

Editorial status

Reviewed by clinical staff

Written by Tim Francis, SUD Content Specialist. This guide is educational. Read our clinical review and sources policy.

Sources